Suchergebnisse - "monoamine oxidase a"

In silico approach for Parkinson's disease by targeting MAOB with pterostilbene.

Autoren: Singh, Supriya Hasija, Yasha

Quelle: AIP Conference Proceedings. 2025, Vol. 3297 Issue 1, p1-6. 6p.

Schlagwörter: *PARKINSON'S disease, *MONOAMINE oxidase, *MOLECULAR docking, *OXIDATIVE stress, *ANTIOXIDANTS, *DOPAMINERGIC neurons, *NEURODEGENERATION

Rational design of MAO-B-activated fluorescent probe for activity evaluation and its biomedical applications.

Autoren: Yan, Fei Niu, Junxiang Zhang, Yue et al.

Quelle: Free Radical Biology & Medicine. Dec2025, Vol. 241, p236-242. 7p.

Schlagwörter: *MONOAMINE oxidase, *MONOAMINE oxidase inhibitors, *CHINESE medicine, *CHEMICAL inhibitors, *FLUORESCENT probes, *OXIDATIVE stress, *TREATMENT effectiveness

Design, Synthesis, Biological Evaluation, and In Silico Study of Tetrahydropyridines as Prospective Monoamine Oxidase Inhibitors.

Autoren: Khan, Obaid ur Rehman Khan, Bilal Ahmad Hamdani, Syeda Shamila et al.

Quelle: ChemistryOpen. Oct2025, Vol. 14 Issue 10, p1-10. 10p.

Schlagwörter: *MONOAMINE oxidase inhibitors, *MONOAMINE oxidase, *PARKINSON'S disease, *ANTIDEPRESSANTS, *ALZHEIMER'S patients, *PIPERIDINE, *MOLECULAR docking

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson's Disease: An Update.

Autoren: Ribeiro, Luana Vergueiro Massuda, Larissa Emika Gontijo, Vanessa Silva et al.

Quelle: Pharmaceuticals (14248247). Oct2025, Vol. 18 Issue 10, p1526. 79p.

Schlagwörter: *MONOAMINE oxidase inhibitors, *PARKINSON'S disease, *PHARMACEUTICAL chemistry, *NEURODEGENERATION, *DOPAMINE, *OXIDATIVE stress, *MONOAMINE oxidase, *THERAPEUTICS

GC-MS Analysis and Molecular Docking Studies of Lavandula dentata Leaves Extract of Taif Region, Saudi Arabia.

Autoren: Hamad Mohamed, Hanan Ramadan Hussien, Nahed Ahmed

Quelle: Indian Journal of Animal Research. Oct2024, Vol. 58 Issue 10, p1677-1687. 11p.

Schlagworte: Monoamine oxidase, Amyotrophic lateral sclerosis, Gas chromatography/Mass spectrometry (GC-MS), Hydrophobic interactions, Molecular docking, Lavenders

Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses.

Autoren: Dormegny-Jeanjean, Ludovic C. Lenoir, Suzie Humbert, Ilia et al.

Quelle: Pharmacopsychiatry. Nov2025, Vol. 58 Issue 6, p273-283. 11p.

Schlagwörter: *MONOAMINE oxidase inhibitors, *BAYESIAN analysis, *HEMODYNAMICS, *FIELD research, *HYPERTENSION, *ANTIDEPRESSANTS, *HEART beat, *DRUGS

New Acyl Hydrazone Derivatives: Synthesis, Conformational Analysis by NMR Spectroscopy, and Enzyme Inhibitory and Antioxidant Activities in Alzheimer Disease.

Autoren: Taşci, Hayrünnisa Sağlık, Begüm Nurpelin Teke Tuncel, Şenel et al.

Quelle: Polycyclic Aromatic Compounds. Oct2025, p1-23. 23p. 12 Illustrations.

Schlagwörter: *MONOAMINE oxidase inhibitors, *ALZHEIMER'S disease, *ANTIOXIDANTS, *NUCLEAR magnetic resonance spectroscopy, *NEUROINFLAMMATION, *CHEMICAL synthesis, *ENZYME inhibitors, *HYDRAZONE derivatives

Investigating Amphoteric 3,4′-Biscoumarin-Based ortho -[(Dialkylamino)methyl]phenols as Dual MAO and ChE Inhibitors.

Autoren: Petrou, Anthi Deruvo, Caterina Purgatorio, Rosa et al.

Quelle: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10197. 21p.

Schlagwörter: *MONOAMINE oxidase inhibitors, *CHEMICAL inhibitors, *AMPHOTERIC substances, *MANNICH bases, *COUMARIN derivatives, *NEURODEGENERATION, *CHEMINFORMATICS, *MOLECULAR docking

Immunometabolism perturbations in post-COVID-19 condition: interleukin-6 and monoamine oxidase interactions drive neuropsychiatric syndromes.

Autoren: Ogando, Natacha S. Elaish, Mohamed Mahabadi, Hajar Miranzadeh et al.

Quelle: Brain, Behavior & Immunity. Oct2025, Vol. 129, p690-708. 19p.

Schlagwörter: *INTERLEUKIN-6, *MONOAMINE oxidase, *ANXIETY, *NEUROBEHAVIORAL disorders, *SARS-CoV-2, *MENTAL depression, *COVID-19 pandemic, *IMMUNOLOGY

[125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimers Disease Hippocampus-Subiculum and Evaluation of Drug Effects.

Autoren: Karim, Fariha Delaney, Brooke Mondal, Rommani et al.

Quelle: Synapse. 79(4)

Schlagwörter: Hippocampus, Humans, Alzheimer Disease, Iodine Radioisotopes, Harmine, Carbolines, Monoamine Oxidase, tau Proteins, Monoamine Oxidase Inhibitors, Aged, Aged, 80 and over, Middle Aged, Female, Male, Protein-Tyrosine Kinases, Protein Serine-Threonine Kinases, Dyrk Kinases

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/42g3p7cq
https://escholarship.org/content/qt42g3p7cq/qt42g3p7cq.pdf

Assembling of phenyl substituted halogens in the C3-position of substituted isatins by mono wave assisted synthesis: development of a new class of monoamine oxidase inhibitors.

Autoren: Parambi, Della Grace Thomas Cloete, Stephanus J. Kumar, Sunil et al.

Quelle: Journal of Computer-Aided Molecular Design. 9/19/2025, Vol. 39 Issue 1, p1-13. 13p.

Schlagwörter: *MONOAMINE oxidase inhibitors, *NEUROLOGICAL disorders, *PHARMACOKINETICS, *BLOOD-brain barrier, *MOLECULAR docking, *HALOGENATION, *ISATIN

Comment je diagnostique un syndrome parkinsonien et comment je le prends en charge en médecine générale ?

Alternate Title: How do I diagnose Parkinsonian syndrome and how do I manage it in general medicine?

Autoren: Tranchant, Christine¹ Christine.Tranchant@chru-strasbourg.fr

Quelle: Cahiers Santé - Médecine Thérapeutique. Sep/Oct2025, Vol. 34 Issue 5, p344-347. 4p.

Schlagwörter: *HYPOKINESIA, *MONOAMINE oxidase, *DOPA, *PHYSICAL therapy, *PHYSIOLOGICAL therapeutics

Biocatalytic production of a monoamine oxidase B/catechol-O-methyltransferase inhibitor from piperine by engineered P450 BM3.

Autoren: Brzoski, Mariusz Irudal, Samuele Gazzano, Elena et al.

Quelle: Journal of Biotechnology. Sep2025, Vol. 405, p8-16. 9p.

Schlagwörter: *BIOACTIVE compounds, *MONOAMINE oxidase inhibitors, *BIOLOGICAL assay, *CYTOCHROME P-450, *PARKINSON'S disease

Deploying the drug repurposing approach for the identification of selective monoamine oxidase-B inhibitors against neurological disabilities: an in Silico and in vitro approach.

Autoren: Mohany, Mohamed Al-Rejaie, Salim S. Babu, M. Arockia et al.

Quelle: Journal of Computer-Aided Molecular Design. 8/29/2025, Vol. 39 Issue 1, p1-13. 13p.

Schlagwörter: *MONOAMINE oxidase, *NEUROLOGICAL disorders, *SELECTIVE estrogen receptor modulators, *DRUG repositioning, *VIRTUAL high-throughput screening (Drug development), *DOPAMINE, *EPICATECHIN, *DOPAMINE agents

Selective Nanopore Detection of Monoamine Oxidase A and B in a Single Sample.

Autoren: Wu, Xueshuang Hao, Wenying Yan, Shuaihu et al.

Quelle: Angewandte Chemie. 8/25/2025, Vol. 137 Issue 35, p1-7. 7p.

Schlagwörter: *MONOAMINE oxidase, *BIOMARKERS, *DIAGNOSIS, *MEDICAL research, *NANOPORES, *BIOGENIC amines

Investigation of the Interaction of Monoamine Oxidase (MAO) Inhibitor Biscoumarins with Hemoglobin and Albumin Using Multi-Spectroscopic Techniques and Molecular Docking.

Autoren: Mutafoğlu, Bengü Sema Meletli, Furkan Danış, Özkan

Quelle: Analytical Letters. 2025, Vol. 58 Issue 12, p2032-2055. 24p.

Schlagwörter: *MONOAMINE oxidase, *AMINO acid residues, *MOLECULAR docking, *FLUORESCENCE quenching, *SERUM albumin, *PROTEIN-ligand interactions

Extraction and hydrolysis of Chlamydomonas reinhardtii protein and in vitro MAO-A inhibitory activity of hydrolysates.

Autoren: Mao, Ya Liu, Meiting Su, Keying et al.

Quelle: Journal of Applied Phycology. Aug2025, Vol. 37 Issue 4, p2407-2418. 12p.

Schlagwörter: *CHLAMYDOMONAS reinhardtii, *MONOAMINE oxidase inhibitors, *SONICATION, *ALKALINE protease, *ENZYMES, *PROTEIN fractionation, *DIETARY bioactive peptides

Evaluating the inhibitory efficacy of Oxalis phytocompounds on monoamine oxidase B: An integrated approach targeting age related neurodegenerative diseases through molecular docking and dynamics simulations.

Autoren: Shrestha, Ram Lal M. C., Shiva Tamang, Ashika et al.

Quelle: PLoS ONE. 7/30/2025, Vol. 20 Issue 7, p1-23. 23p.

Schlagwörter: *MONOAMINE oxidase, *NEURODEGENERATION, *MOLECULAR docking, *MOLECULAR dynamics, *THERAPEUTICS, *HERBACEOUS plants, *LIGAND binding (Biochemistry), *PHYTOCHEMICALS

Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights.

Autoren: Thai, K.-M. Pham, D.-T. Ngo, T.-M et al.

Quelle: SAR & QSAR in Environmental Research. Jul2025, Vol. 36 Issue 7, p583-619. 37p.

Schlagwörter: *PARKINSON'S disease, *MONOAMINE oxidase, *DRUG discovery, *MOLECULAR docking, *CHEMICAL inhibitors, *COMPUTER-assisted drug design, *MOLECULAR dynamics

Novel Au(I)- and Ag(I)-NHC Complexes with N -Boc-Protected Proline as Potential Candidates for Neurodegenerative Disorders.

Autoren: Ceramella, Jessica D'Amato, Assunta Procopio, Francesca et al.

Quelle: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 13, p6116. 20p.

Schlagwörter: *NEURODEGENERATION, *MONOAMINE oxidase inhibitors, *SILVER compounds, *METAL carbenes, *ACETYLCHOLINESTERASE inhibitors, *ANTIOXIDANTS, *GOLD compounds, *ANTI-inflammatory agents